Rationale: Reductions in mortality following improvements in air quality were documented by several studies, and our group found, in an earlier analysis, that decreasing particulate levels attenuate lung function decline in adults. Objectives: We investigated whether decreases in particulates with an aerodynamic diameter of less than 10 mm (PM 10 ) were associated with lower rates of reporting respiratory symptoms (i.e., decreased morbidity) on follow-up.
Several studies have reported cross-sectional associations between long-term exposure to air pollution and respiratory disease in adults (1) (2) (3) (4) (5) (6) (7) . Recently three studies have observed substantial decreases in adult mortality after reductions in air pollution (8) (9) (10) . However, with two exceptions (11, 12) , the only studies to address whether gradual improvements in air quality can lead to improvements in respiratory symptoms or lung function have been in children. A number of cross-sectional studies of successive age cohorts of children have documented reductions in respiratory symptoms following decreases in air pollution levels (13) (14) (15) (16) . But because there was no follow-up of subjects, these results did not imply reversibility of symptoms. The gap was closed by a prospective cohort study in Californian children, which showed that moving to a less polluted area resulted in accelerated lung-function growth in children and suggested that previously documented impairments could be reversed (17) . Similarly, we found attenuations in age-related lung-function decline among persons who had experienced decreases in ambient residential PM 10 -levels during the 11 years of follow-up (12) . These findings suggested that gradual decreases in air pollution levels might also lead to a concurrent reduction in respiratory morbidity among adults. This hypothesis gave rise to the present analysis. Its confirmation is relevant for public health because the significance of a decrease in air pollution exposure depends on the
AT A GLANCE COMMENTARY Scientific Knowledge on the Subject
Major reductions in air pollutant levels have beneficial effects on adult mortality and on respiratory morbidity in children. Moreover, decreasing particulate levels is associated with a slowed age-related lung function decline in adults.
What This Study Adds to the Field
The results of the present study suggest that, in addition to being beneficial for lung function, reductions in particulate levels also lead to a decrease in respiratory symptoms among adults. amount of time before health effects can be observed. If, contrary to our hypothesis, most of the damage caused by past exposure were irreversible, then beneficial effects of improvements in air quality would only manifest themselves gradually and predominantly in the younger cohorts.
The Swiss study on air pollution and lung disease in adults (SAPALDIA) cohort study was originally designed to assess respiratory health in the adult population of Switzerland and to study potential associations between long-term exposure to air pollution and various respiratory health parameters. In the original study sample of 9,651 subjects from eight areas, we found the average levels of forced vital capacity to be negatively associated with ambient levels of particulates with an aerodynamic diameter of less than 10 mm (PM 10 ) across areas (18) and with estimated home outdoor and personal exposure to nitrogen dioxide (NO 2 ) within areas (19) . Moreover, ambient levels of PM 10 were positively associated with the prevalence of breathlessness at rest and of chronic bronchitis symptoms (3) .
In 2002, 8,047 subjects were reassessed following the same study protocol as in 1991. One of the primary objectives of the second survey was to study longitudinal changes in respiratory symptoms and in lung function and their relation to changes in air pollutant levels. For this purpose, we estimated individual PM 10 -exposure trajectories for all subjects based on their residential histories between 1991 and 2002.
Preliminary results to this article have been previously reported (20) .
METHODS Study Population and Health Examinations
At baseline in 1991 (SAPALDIA1), the cohort consisted of 9,651 randomly selected adults, 18 to 60 years of age, from eight diverse areas of Switzerland. Subjects underwent a detailed health examination consisting of an extensive computer-assisted interview on respiratory and allergic diseases and personal and environmental risk factors, measurements of pulmonary function, and assessments of atopic sensitizations (21) . In 2002 (SAPALDIA2), most assessments were repeated and some were expanded (22) . To be included in the present analysis, study subjects had to have lived at the same address for at least 1 year before the baseline assessment and had to provide information on respiratory symptoms and smoking status in the second assessment. All SAPALDIA study protocols were approved by the Ethics Committee of the Swiss Academy of Medical Sciences and by the local Ethics Committees.
Assignment of Individual Exposure Estimates
The marker of ambient air pollution considered was PM 10 (i.e., particulates with an aerodynamic diameter of less than 10 mm). PM 10 concentrations outside of each subject's residence were estimated for the years 1990 and 2000 using a validated dispersion model (with different emissions inventories for each year), with a spatial resolution of 200 3 200 meters. Average exposure levels for the other years were estimated using an algorithm involving annual trends from fixed monitoring stations and subjects' residential histories. Details of these methods and the model evaluation were given in (23) . The exposure variable used in the present analysis was the difference between the estimated average PM 10 level outside a subject's home(s) in the 12 months before the second assessment in 2002 and the corresponding mean level in the 12 months before the first visit. This variable is referred to as estimated change in home outdoor PM 10 and will be abbreviated DPM 10 .
Definition of Symptom Categories Considered
Regular cough (regular phlegm) was defined by an affirmative answer to at least one of the following questions ''Do you usually cough (bring up phlegm from your chest) first thing in the morning?'' and/or ''Do you usually cough (bring up phlegm from your chest) during the day or at night?'' Chronic cough or phlegm was defined as chronic cough and/or chronic phlegm, with ''chronic'' being defined by the presence of the respective symptoms during at least 3 months per year for at least two years. Wheezing was defined by an affirmative answer to the question ''Have you had wheezing or whistling in the chest at any time in the last 12 months?''
Wheezing with dyspnea was defined according to the question ''Have you had trouble breathing when you had this wheezing or whistling in your chest?'' And wheezing without a cold was defined according to the question ''Have you had this wheezing or whistling in your chest when you did not have a cold?''
Statistical Analysis
Logistic regression models were used to describe the odds of reporting a given respiratory symptom in SAPALDIA2 as a function of DPM 10 . Because symptom status at baseline is the strongest predictor of symptoms at follow-up and modifies the role of other predictor variables, analyses were stratified by symptom status at baseline. We also controlled for sex, age, smoking status at SAPALDIA1 (smoker, ex-smoker, never-smoker), smoking status at SAPALDIA2 (smoker, nonsmoker), the seasons of the two interviews, and a large number of baseline exposure variables and risk factors (see footnote of Table 3 and online supplement). The function GLLAMM from STATA (Stata, release 9; StataCorp LP, College Station, TX) was used to incorporate random area effects accounting for uncontrolled differences between the eight original study samples. For each outcome, the two associations with DPM 10 (for incidence and persistence) were subject to a Chi 2 test with two degrees of freedom to assess the global null hypothesis of absence of any association. The shape of associations between DPM 10 and new or persistent symptom reports was explored using natural splines (24) . We also estimated the percentage of reduction in the number of symptom cases attributable to the observed decreases in PM 10 levels during followup. Sensitivity analyses were performed in different subsamples using interaction terms between specific individual characteristics and DPM 10 . Respective details are given in the online supplement.
RESULTS
We could include up to 7,019 of the 8,047 participants of SAPALDIA2 in the present analysis. A total of 905 subjects did not provide complete information on symptoms and covariates. Geocoding of addresses failed in 57 subjects and 66 subjects were excluded because they had relocated less than a year before the first health assessment ( Figure 1 ). For the majority of subjects in our sample, residential addresses at the time of the two surveys could be geocoded exactly (n 5 5,772, 82.2%) using a nearest-neighbor address (n 5 755, 10.8%) or the median house number of the respective street (n 5 492, 7.0%).
Differences between the sample of the present analysis and subjects who only participated in SAPALDIA1 or provided incomplete data are shown in Table 1 . Compared with the nonparticipants, the study sample had a higher mean age (by 1.2 yr) and a lower mean body mass index (by 0.5 kg/m 2 ). Moreover, it included higher proportions of women, of nonsmokers at SAPALDIA1, and of Swiss nationals. However, there was no statistically significant difference between the two samples with respect to the average change in home outdoor PM 10 between surveys. Differences between SAPALDIA2 participants and subjects having only participated in the baseline survey were previously described in detail (22) . Table 2 shows the respective fractions of subjects with persistent, remitting, and newly emerging symptoms. Compared with 1991, symptom reports were slightly more frequent in 2002, with the prevalence of regular cough, regular phlegm, and wheezing ranging between 14 and 17%, and the prevalence of chronic cough or phlegm, wheezing with dyspnea, and wheezing without cold reaching 12.9, 6.6, and 8.2%, respectively. The largest relative increase (i.e., by 45%) was observed for chronic cough or phlegm. All symptoms were labile: more than 50% of subjects reporting a given symptom in 1991 no longer reported it in 2002. The remission rate was highest for wheezing without cold (64%). In persistent smokers, however, remission rates were less than 50% for regular cough, regular phlegm, chronic cough or phlegm and wheezing. In both surveys, prevalence of symptoms was highest among persistent smokers. Among subjects who quit smoking between 1991 and 2002, reports of all symptoms except wheezing substantially decreased from 1991 to 2002.
On average, home outdoor levels of PM 10 decreased by 6.2 mg/m 3 in our study population during the 11 years of followup (Table 1 ). Figure 2A shows the distribution of average PM 10 levels outside the subjects' homes in the 12 months preceding the two examinations, grouped by the area of residence at SAPALDIA1. For all study areas, the distribution shifted toward lower values from the first to the second survey. This shift was particularly pronounced in Lugano (with a mean decrease of 12.0 mg/m 3 ) and smallest in the alpine areas of Davos and Montana (with mean decreases of 1.5 mg/m 3 and 3.3 mg/m 3 , respectively). Figure 2B shows the distribution of individual differences between follow-up and baseline levels. The interquartile ranges (boxes) were very narrow for the four rural areas of Wald, Payerne, Davos, and Montana and widest for the three urban areas of Basel, Lugano, and Geneva. The widest distribution of change was observed in Lugano. Table 3 shows the estimated adjusted odds ratios for the symptom reports in 2002 for a 10 mg/m 3 decrement in PM 10 exposure between the two surveys stratified by symptom status in 1991. The variables adjusted for are listed in a footnote of the table. For persistent reports of symptoms, the odds ratios ranged between 0.50 and 0.82. Furthermore, declining levels of PM 10 were associated with fewer new reports of most of the symptoms (except wheezing and wheezing without a cold). Decreased PM 10 was protective against persistence of regular cough, chronic cough or phlegm, wheezing, and wheezing without a cold both in the entire sample and in the subsample of persistent nonsmokers. In this subsample, effects on persistent reports of regular cough and chronic cough or phlegm were particularly strong. When we tested the joint hypothesis of no association between DPM 10 and symptom incidence or persistence (Table 4) , significant results were obtained for regular cough, chronic cough or phlegm and wheezing. A sensitivity analysis, including additional follow-up variables (e.g., pack years between surveys) at the expense of a reduction in sample size, provided similar results (Table E6) . Figure 3 shows the estimated covariate-adjusted probability of reporting regular cough and wheezing, respectively, as a function of the change in home outdoor PM 10 between assessments and of the status of the respective symptom in 1991. For regular cough, the estimated adjusted probability of new reports ranged between 7 and 18%, whereas the corresponding probability of persistent reports ranged between 16 and 70%. With wheezing, only the estimated adjusted probability of persistent reports was related to a change in PM 10 and ranged from 15 to 80%. In all four cases, the model with just a linear term of DPM 10 appeared to fit the data best among a wide set of candidate models. For the other four symptoms, the corresponding figures are given in the online supplement ( Figure E3 ). Table 5 shows the decreases in the numbers of symptom cases (per 10,000 persons) that our model attributes to the observed changes in PM 10 levels (i.e., as compared with a counterfactual scenario with constant PM 10 levels over time). The corresponding estimates for regular cough, chronic cough or phlegm and wheezing with dyspnea are statistically significant. The highest number of cases prevented was estimated for regular cough, with 259 cases/10,000 persons. There were some sex-specific differences, but they were not statistically significant (Tables E7 and E8 ).
We also found that associations got weaker with increasing age of the subjects. But none of these differences or interactions was statistically significant. However, associations were stronger in subjects who had always lived in the same area. Most of these differences were nonsignificant, but the beneficial effect of decreases in PM 10 on wheezing with dyspnea was seen only in subjects having always lived in the same area. Similarly, most associations were slightly stronger among subjects whose addresses could be geocoded exactly. The decline in PM 10 and the baseline level of PM 10 interacted negatively in their joint effect on most of the symptom reports, indicating that the protective effects of a fixed decrease in PM 10 exposure tended to be larger if initial levels were lower. These interactions were marginally significant for new reports of regular phlegm (results not shown).
For further sensitivity analysis, we examined symptom prevalence at visit two, controlling for symptom status at visit one in a longitudinal model. We found similar associations, with effect size estimates generally between those found for incidence and persistence in the stratified models (results not shown).
DISCUSSION
Data from our population-based cohort study confirm for the first time that sustained improvements in ambient PM 10 levels can lead to decreases in respiratory symptoms among adults. Not only did decreases in PM 10 reduce the incidence of respiratory symptoms, but they also increased the likelihood of recovery in persons symptomatic at baseline. Although changes Values are expressed as %, or n, as indicated. * The smoking categories shown are not exhaustive (e.g., subjects who resumed smoking between studies are not included). Moreover, information on pack-years smoked between studies is missing in subjects having filled in a shorter questionnaire in the second survey. Therefore, the numbers in the smoking categories shown don't add up to the numbers in the entire sample.
† Never and ex-smokers at both SAPALDIA 1 & 2 and pack-years 5 0 between SAPALDIA 1 and 2. ‡ Smokers at SAPALDIA1 and ex-smokers at SAPALDIA2.
in reports of symptoms related to bronchitis (cough and phlegm) were associated with changes in PM 10 independent of symptom status at baseline, reports of wheezing symptoms at the follow-up assessment were more strongly associated with changes in PM 10 in the subgroup of persons who had reported such symptoms at baseline. This is plausible, given that current evidence only supports a role of traffic-related air pollution, and not PM 10 in childhood incidence of asthma (25) . Moreover, when we restricted our analyses to subjects who had always resided in the same area, effect sizes got more protective, suggesting that measurement error in exposure was biasing our results toward the null. Similar results on improvements in respiratory conditions as a result of reductions in air pollution have only been known for children so far (13, 14, 16, 17) , and most of these studies relied on local central monitoring, whereas our study uses a validated dispersion model to estimate individual exposures. Some of these effects were substantial, such as the odds ratio of 0.55 for the persistence of regular cough, and an overall reduction of 259 cases with that symptom per 10,000 persons, indicating that reductions in particle concentrations could have substantial benefits.
Interpretation of Results
We observed a moderate increase in the prevalence of respiratory symptoms after 11 years of follow-up and considerable fluctuations in reporting symptoms between the two surveys in 1991 and 2002. Compared with SAPALDIA, the longitudinal Hordaland study in Western Norway found a smaller increase in the prevalence of cough symptoms but a similar increase in wheezing prevalence among its 2,800 adult study participants between 1985 and 1996/97 (26), whereas the European Community Respiratory Health Survey saw no increase in wheezing prevalence, but it did observe an increase in asthma within its younger cohort (27) . The rate of symptom remissions in Norway was similar to our findings, with cumulative remission rates between 42 and 58% for chronic cough, cough with phlegm, and wheezing. As in SAPALDIA, the remission rate was lower in smokers, and smoking cessation had a beneficial effect (28) . High fluctuations and remission rates of reports of chronic respiratory symptoms were also reported from studies in The Netherlands (29) , the United States (30) , and from an early study in London (31) . The authors of the London study interpreted phlegm production as a temporary effect of bronchial infection, remitting with decreasing exposure to smoking and/or air pollution.
The prevalence of chronic cough or phlegm but not of wheezing symptoms was associated with PM 10 in the SAPALDIA baseline study (3) . At that time, PM 10 measurements from only one central monitoring station per study area were available. In the present study, with individual estimates of home outdoor PM 10 exposure, we could show that decreases in outdoor PM 10 levels over the 11 years of follow-up were associated with lower rates of new and persistent reports of chronic cough or phlegm. Similar longitudinal associations were found for the other symptoms (except wheezing without a cold) and we estimated that their prevalence would have been between 8 and 17% higher in 2002 if mean PM 10 levels had remained constant over time. These effects were seen despite the moderate to low air pollutant levels in Switzerland. They suggest that the respiratory health of adult populations may adapt relatively fast to changing levels of ambient air pollution. This is also consistent with a report from the Harvard Six City Study indicating that changes in PM 2.5 exposure over a similar time interval were associated with changes in mortality risk on follow-up (10) . A more recent analysis of these data showed that the effects of particles on mortality were driven by exposure in the previous 2 years (32).
Previously, our group reported associations between respiratory symptoms and traffic exposure indicators (e.g., closeness of streets and street densities) for both SAPALDIA surveys (33) . These associations were cross-sectional and suggested potentially stronger effects from traffic on the prevalence of regular cough, regular phlegm, wheezing, and attacks of breathlessness. However, due to a lack of data on changes in traffic frequencies and emissions, we were unable to address whether changes in the level of traffic-related particles were associated with changes in symptom reports between the two surveys. Moreover, given that our model-based PM 10 estimates do not capture local traffic particles (23), such associations would be largely independent of the ones observed in the present study.
Potential Sources of Bias
A potential source of bias in all cohort studies is loss to follow-up. By including only a minimum of follow-up covariates in our model, we could include 70% of the original participants in our analyses. To examine whether more detailed information on follow-up covariates would change the results, we also performed analyses in a restricted sample with more complete information. This led to only minor changes in the results. Moreover, these changes were mostly explained by the restriction of the sample and not by the inclusion of additional covariates. An alternative analysis, including the likelihood of participation in the second survey as a potential effect modifier, suggested that we might have slightly underestimated the effects on cough and phlegm and slightly overestimated the effects on wheezing. This would be consistent with the slightly stronger effects for wheezing in the model with more covariates and fewer subjects (see Figure E6 ).
Our exposure variable was derived from a dispersion model for home outdoor PM 10 . Generally, associations are weakened if exposure is misclassified. But effect sizes may also be overestimated if exposure contrasts are systematically underestimated. This is unlikely in our case, because validation of our exposure model has shown good average agreement between modeled and measured PM 10 values across and within study areas (23) .
Because changes in exposure were generally larger in persons who had moved between surveys, they might have been correlated with socioeconomic factors. In as much as these factors could be assessed at baseline, they were controlled for in our analyses. Moreover, the observed beneficial effects of reduced exposure to PM 10 were slightly stronger among nonmovers than among the entire sample, showing that our results were not driven by the movers.
The magnitude and distribution of change in exposure differed across areas. Thus, there is a potential risk that associations could have been confounded by unexplained factors varying between areas. However, area-specific slopes did not improve the model for most of the outcomes studied except for new reports of wheezing with dyspnea. Moreover, the results from models with fixed area intercepts adjusting for any previously unexplained differences between areas were only slightly weaker than the ones of the random intercept models (results not shown).
We previously reported that change in PM 10 exposure was associated with change in lung function in this cohort, with reduced exposure associated with a slower rate of pulmonary function decline. These results strengthen the evidence that reducing exposure to particles improves respiratory health. They also raise the question as to how independent the results are. Whereas respiratory symptoms and level of lung function are correlated, the correlation is modest. To test the hypothesis that change in FEV 1 is on the causal pathway between change in PM 10 exposure and respiratory symptoms, we repeated our analyses controlling for FEV 1 (results not shown). Control for FEV 1 had little impact on the protective effects of air pollution reduction on symptom incidence or persistence, suggesting these are independent effects.
Strengths and Limitations of the Present Study
Our study involves a large population-based cohort including more than 70% of the initially recruited subjects. Moreover, the availability of detailed individual residential histories and a validated PM 10 dispersion model enabled the study of associations between changes in respiratory symptom reports and changes in individual estimates of home outdoor PM 10 .
This study also has several limitations. We do not know the time course of different size and source fractions of particles between 1991 and 2002. Measurements of PM 2.5 were initiated in Switzerland only in 1998 after most of the decrease in PM 10 levels had already happened. However, PM 2.5 levels were highly correlated with PM 10 levels between 1998 and 2001 and there is no reason to think that this was different before 1998 (34) . PM 10 levels outside individual residences capture only part of individual exposure to particles. However, they have been shown to strongly correlate with total individual exposure to particulate matter (35, 36) . Thus, the direction of bias of our effect estimates depends on the difference in exposure contrasts between the two measures. If contrasts were actually larger for residential than for average personal levels, as some previous results of ours on individual exposure to NO 2 might indicate (19) , then our effect estimates would be too low.
Because PM 10 exposure contrasts have decreased during the follow-up period, there is a strong negative correlation between individual change in PM 10 exposure and individual average exposure between the two studies (r 5 20.63). Thus, we could For definition of abbreviation, see Table 3 . * Annual home outdoor PM 10 was defined as the estimated 12-month mean of home outdoor PM 10 before the respective interview.
† See Table 2 footnote for subject categories. ‡ Chi 2 -test with two degrees of freedom using the sum of the squared t-values of the two stratum-specific parameter estimates as test statistic. Definition of abbreviation: PM 10 5 particulates with an aerodynamic diameter of less than 10 mm. * Annual home outdoor PM 10 was defined as the estimated 12-month mean of home outdoor PM 10 before the respective interview. † Adjusted for baseline variables (sex, age, level of education, Swiss citizenship, body mass index, parental smoking, parental history of asthma/atopy, early respiratory infection, smoking status, pack-years, daily number of cigarettes, years since smoking cessation, passive smoking in general/at work, occupational exposure to airborne irritants), season of each interview, and smoking status at follow-up (see online supplement for details).
‡ Subjects without respective symptom report in 1991.
x Subjects with respective symptom report in 1991.
not estimate the independent role of interval exposure reliably. The use of the change in annual PM 10 levels before health assessments as the primary exposure measure may be justified if the health parameters studied adapt relatively fast to environmental changes and reflect effects of more recent rather than of long-term exposure. Our results suggest that this may indeed be the case for most of the outcomes studied. Nevertheless, our interaction results suggest that the beneficial effects of reduced PM 10 exposure were slightly weaker if initial levels were higher and if persons were older. This may indicate that the degree of reversibility of respiratory conditions decreases with age and with increasing level of past exposure. Alternatively, the presence of an adaptation mechanism might make the percentage of change in exposure more important than the absolute change, which would result in larger improvements in health for the same exposure decrement among individuals with lower baseline exposure.
In conclusion, the present results on respiratory symptoms are in line with our previous findings that decreasing PM 10 levels were associated with an attenuated age-related lung- function decline. Both results indicate that reductions in ambient particle concentrations may have beneficial effects on the respiratory health of adults within few years even in areas with moderate to low levels of air pollution. Moreover, they suggest that efforts to reduce particulate pollution should be sustained irrespective of improvements already achieved, as the potential for reversibility of symptoms was even higher at lower initial exposure levels in our study.
